ARCHIVES

Chart of FY 1991 Budget For NCI By Mechanism

This article is from The Cancer Letter archive.

Vol. 16 No. 05 | February 2, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

In Brief: Reagan/Congress Budget Compromise Seems Likely, Would Loosen FY 1982 Spending Limits On NCI

December 11, 1981

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

FDA Designates Zometa For Priority Review.

November 30, 2001

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997